胆汁酸隔离剂的使用和胃癌:全国回顾性队列分析
Andrew Canakis1, Amy Lee2, Alese E Halvorson3
1Division of Gastroenterology and Hepatology, University of Maryland School of Medicine, Baltimore, Maryland, USA.
Clinical and translational gastroenterology
|August 22, 2023
概括
胆酸分离剂药物的使用可能会降低胃癌的风险. 需要进一步的研究来证实这种对心脏和非心脏胃癌的潜在保护作用.
科学领域:
- 胃肠病学 胃肠病学
- 在瘤学瘤学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 胆汁酸与胃癌发生有关.
- 胆酸分离剂药物 (BAMs) 在预防胃癌 (GC) 中的潜在作用正在调查中.
研究的目的:
- 调查胆汁酸分离剂药物使用与胃癌发病率之间的关联.
- 探索BAM是否对心脏和非心脏胃癌有保护作用.
主要方法:
- 分析了一组417239名退伍军人在2000年至2020年期间接受过Helicobacter pylori检测的队列.
- 暴露被定义为指数日期前5年填写的BAM处方的数量.
- 事件GC及其解剖学子站点是主要结果,使用Kaplan-Meier曲线和Cox比例危险模型进行分析.
主要成果:
- 与未暴露的个体相比,具有4个或更多BAM填充的个体的GC发病率在数值上较低 (aHR0.71;95%CI,0.37-1.36).
- BAM使用和GC发病率之间的关联在不同的解剖学子站点中是一致的.
- 观察到的关联的置信区间很宽,表明不确定性.
结论:
- 胆汁酸分离剂药物可能会对心脏和非心脏胃癌产生保护作用.
- 需要进一步的研究和外部验证来证实这些初步发现.
相关概念视频
Acid Suppressive Drugs for Peptic Ulcer Disease: Proton Pump Inhibitors
471
Peptic ulcers, often induced by H. pylori infections or NSAID usage, arise from disruptions in the delicate balance of gastric acid production. Peptic ulcers stem from heightened gastric acid levels due to H. pylori infections or NSAID use. The protective mucus layer diminishes in the presence of these factors, allowing gastric acid to erode the stomach lining and form ulcers.
Gastric acid, a potent cocktail of hydrogen and chloride ions, is produced in specialized parietal cells within the...
Gastric acid, a potent cocktail of hydrogen and chloride ions, is produced in specialized parietal cells within the...
471
Acid Suppressive Drugs for Peptic Ulcer Disease: Histamine H2-Receptor Antagonists
516
Histamine H2 receptors, which are intricately located on the basolateral membrane of parietal cells, play a crucial role in modulating gastric acid secretion. When released from enterochromaffin-like cells, histamine engages H2 receptors, initiating the cyclic AMP (cAMP) pathway. In this pathway, adenylyl cyclase converts ATP into cAMP, elevating intracellular cAMP levels. The activation of protein kinase A follows, stimulating the proton pump. This stimulation prompts the secretion of hydrogen...
516
Acid Suppressive Drugs for Peptic Ulcer Disease: Antacids
400
In the complex environment of the gastric lumen, excessive acid secretion can lead to the formation or worsening of ulcers within the delicate mucosal layer. Antacids, such as sodium bicarbonate and calcium carbonate, provide relief by neutralizing this acid, transforming it into harmless salt and water. This neutralization process raises the gastric pH from a highly acidic level of 1 to a more basic 3-4, reducing the acidity within the stomach.
However, this neutralization reaction between...
However, this neutralization reaction between...
400
Drugs for Peptic Ulcer Disease: Sucralfate as Mucosal Protective Agents
556
In the intricate landscape of the gastric lumen, excessive acid secretion disrupts the natural defense mechanisms, weakening the mucus-bicarbonate barrier. This vulnerability allows pepsin to infiltrate epithelial cells, digesting mucosal proteins and triggering erosion, leading to ulcer formation.
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
556
Peptic Ulcer Disease IV: Management
110
Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
110
Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents
495
The gastric mucosa produces prostaglandins E2 (PGE2) and prostacyclin (PGI2), crucial in maintaining gastric health. They exert cytoprotective effects, including increasing bicarbonate secretion, releasing protective mucin, reducing gastric acid output, and preventing harmful vasoconstriction. These effects are mediated through various receptors, such as EP1, EP2, EP3, and EP4.
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
495


